Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

"Patient Experiences During and Beyond Treatment with Immune Checkpoint Inhibitors: A Systematic Review of Qualitative Research and Implications for Gastrointestinal Cancer".

Created on 20 Nov 2026

Authors

Laura Collantes-Espinosa, Susanne Cruickshank, Ann Muls

Published in

Seminars in oncology nursing. Volume 43. Issue 1. Pages 152413. Nov 19, 2026. Epub Nov 19, 2026.

Abstract

Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Enhancing Transparency in Reporting the Synthesis of Qualitative Research (ENTREQ) guidelines, we systematically searched PubMed, Embase, MEDLINE, Cochrane Library, Global Health, and Journals@Ovid for studies published between January 2014 and January 2025. Eligible studies were qualitative or mixed methods reports of patient experiences with ICIs; studies that did not report primary patient data were excluded. Quality was assessed using the Joanna Briggs Institute checklist for qualitative research, and the data were analyzed thematically.
Thirty studies published between 2017 and 2025 were included, covering melanoma, lung cancer, and mixed solid tumor populations. Analysis identified six overarching themes: (1) prognostic uncertainty and expectations; (2) information needs and decision-making; (3) treatment burden and physical functioning; (4) psychosocial identity and social roles; (5) emotional and existential well-being; and (6) economic and practical impact. Patients generally perceived ICIs as more tolerable than chemotherapy but reported persistent toxicities, uncertainty regarding treatment durability, and psychosocial strain. The perspectives and experiences of caregivers regarding treatment discontinuation were underrepresented. No study specifically examined GI cancers.
ICIs are experienced as both a lifeline and a burden. The absence of GI cancer perspectives represents a critical research gap in this field. Future studies should prioritize GI cancers, caregivers, long-term survivors, and patients with poor outcomes to inform patient-centered supportive care.
This review highlights the need for personalised communication, routine assessment of psychosocial well-being, and proactive management of irAEs in patients receiving immunotherapy. Multidisciplinary supportive care should address the physical, psychological, practical, and financial impact of treatment. Given the limited representation of GI cancers in the current literature, further work is needed to ensure supportive care strategies adequately reflect the needs of this population.
PROSPERO CRD42024568112.

PMID:
43057181
Bibliographic data and abstract were imported from PubMed on 20 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement